Alcresta Therapeutics Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
106
- Latest Deal Type
-
Div. Recap.
- Financing Rounds
-
7
Alcresta Therapeutics General Information
Description
Developer of enzyme-based products designed to combat gastrointestinal disorders. The company's digestive enzyme cartridge has been designed to mimic the function of pancreatic lipase, enabling patients and the medical community to effectively address acute conditions or chronic diseases caused due to pancreatic insufficiency or fat malabsorption.
Contact Information
Website
www.alcresta.comCorporate Office
- 130 Turner Street, Building 3
- Suite 200
- Waltham, MA 02453
- United States
Corporate Office
- 130 Turner Street, Building 3
- Suite 200
- Waltham, MA 02453
- United States
Alcresta Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Alcresta Therapeutics Comparisons
Industry
Financing
Details
Alcresta Therapeutics Competitors (17)
One of Alcresta Therapeutics’s 17 competitors is Ardelyx, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ardelyx | Formerly VC-backed | Waltham, MA | ||||
| Evoke Pharma | Formerly VC-backed | Solana Beach, CA | ||||
| OrphoMed | Venture Capital-Backed | San Francisco, CA | ||||
| Neurogastrx | Venture Capital-Backed | Woburn, MA | ||||
| RedHill Biopharma | Formerly VC-backed | Raleigh, NC |
Alcresta Therapeutics Patents
Alcresta Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260007579-A1 | Methods and devices for hydrolyzing fats | Pending | 05-Jul-2024 | ||
| US-20260009057-A1 | Methods and devices for hydrolyzing fats | Pending | 05-Jul-2024 | ||
| WO-2026011163-A1 | Methods and devices for hydrolyzing fats | Pending | 05-Jul-2024 | ||
| JP-2026050467-A | Device and method for preparation of nutritional formula | Pending | 11-Sep-2017 | ||
| EP-3949759-B1 | Device for the preparation of a nutritional formula | Active | 11-Sep-2017 | A23L29/06 |
Alcresta Therapeutics Signals
Alcresta Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Alcresta Therapeutics FAQs
-
When was Alcresta Therapeutics founded?
Alcresta Therapeutics was founded in 2011.
-
Where is Alcresta Therapeutics headquartered?
Alcresta Therapeutics is headquartered in Waltham, MA.
-
What is the size of Alcresta Therapeutics?
Alcresta Therapeutics has 106 total employees.
-
What industry is Alcresta Therapeutics in?
Alcresta Therapeutics’s primary industry is Pharmaceuticals.
-
Is Alcresta Therapeutics a private or public company?
Alcresta Therapeutics is a Private company.
-
What is Alcresta Therapeutics’s current revenue?
The current revenue for Alcresta Therapeutics is .
-
How much funding has Alcresta Therapeutics raised over time?
Alcresta Therapeutics has raised $86M.
-
Who are Alcresta Therapeutics’s investors?
Linden (Chicago) has invested in Alcresta Therapeutics.
-
Who are Alcresta Therapeutics’s competitors?
Ardelyx, Evoke Pharma, OrphoMed, Neurogastrx, and RedHill Biopharma are some of the 17 competitors of Alcresta Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process